Matricelf Ltd (TLV:MTLF)
Israel · Delayed Price · Currency is ILS · Price in ILA 527.30
+18.20 (3.57%)
At close: Feb 20, 2026
Matricelf Market Cap
Matricelf has a market cap or net worth of 154.21 million as of February 20, 2026. Its market cap has increased by 164.81% in one year.
Market Cap
154.21M
Enterprise Value
149.95M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
527.30
Market Cap Chart
Since June 20, 2021, Matricelf's market cap has increased from 62.00M to 154.21M, an increase of 148.73%. That is a compound annual growth rate of 21.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 154.21M | 1.49% |
| Dec 31, 2025 | 151.94M | 156.50% |
| Dec 31, 2024 | 59.23M | 18.14% |
| Dec 31, 2023 | 50.14M | -7.15% |
| Dec 29, 2022 | 54.00M | -47.98% |
| Dec 30, 2021 | 103.80M | 67.43% |
| Jun 20, 2021 | 62.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 581.63M |
| Geffen Residence & Renewal | 260.38M |
| Clal Biotechnology Industries | 48.62M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 28.74M |
| XTL Biopharmaceuticals | 25.55M |
| Evogene | 24.91M |
| Purple Biotech | 18.58M |